scholarly journals Tranexamic Acid results in Less Blood Loss in Total Joint Arthroplasty: A Retrospective Study

2018 ◽  
Vol 8 (1) ◽  
pp. 43-48
Author(s):  
Michael P Bolognesi ◽  
Samuel S Wellman ◽  
Taylor R McClellan ◽  
Rhett Hallows ◽  
Kendall E Bradley ◽  
...  
2019 ◽  
Vol 29 (11) ◽  
pp. 356-360
Author(s):  
Khaled M. Yaghmour ◽  
Sam Atkinson ◽  
Emanuele Chisari ◽  
Stephen M. McDonnell ◽  
Wasim Khan

Total joint arthroplasty is associated with significant blood loss, that could result in the need of blood transfusions. Several techniques are being utilised to limit the volume of blood loss, in order to avoid transfusion. In this review, we look at blood loss in total joint arthroplasty and the perioperative strategies to limit the loss of blood. With the use of tranexamic acid gaining popularity, we analyse the published literature on its use in patients undergoing total joint arthroplasty. We have found that published studies favour using tranexamic acid in total joint arthroplasty as a safe and effective method of reducing blood loss.


2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Bishoy N. Saad ◽  
Luke G. Menken ◽  
Sherif Elkattaway ◽  
Frank A. Liporace ◽  
Richard S. Yoon

Abstract Backgroud Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusion rates, and length of hospital stay in revision joint replacement. Methods One-hundred revision total joint arthroplasty patients were retrospectively reviewed [44 revision total hip arthroplasty (THA) and 54 revision total knee arthroplasty (TKA)] who underwent surgery from 2013 to 2016. Fifty-four revision joint patients (23 THA and 31 TKA) received intravenous TXA intra-operatively, while 46 revision joint patients (23 THA/TKA) did not. Primary outcome measures were blood loss, transfusion rates, and length of hospital stay. Results The mean blood loss difference between revision THA patients who received TXA vs. not receiving TXA was 180ml in revision THA patients (p < .005). Mean length of hospital stay was 6 days in non-TXA vs. 3 days in TXA patients (p < .001). Eighteen patients received transfusions in the non-TXA revision TKA group compared to nine patients in the TXA revision TKA group (p < .001). Average length of hospital stay was 5 days in the non-TXA revision TKA group compared to 3 days in the TXA revision TKA group (p < .003). There was no increased risk of thromboembolic complications in TXA groups for either procedure. Conclusions Intravenous TXA reduced length of hospital stay in both revision cohorts, decreased blood loss in revision THA and decreased the rate of transfusion in revision TKA without an increase in thromboembolic complications. Level of Evidence Level III (Case-control study)


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Christiane Schwerdt ◽  
Eric Röhner ◽  
Sabrina Böhle ◽  
Benjamin Jacob ◽  
Georg Matziolis

AbstractOne of the most challenging complications of total knee arthroplasty (TKA) is periprosthetic joint infection (PJI). There is growing evidence of a good anti-infective effect of intrawound vancomycin powder in total joint arthroplasty. At the same time, various different locally applied substances have become popular in total joint arthroplasty. The objective of this study was therefore to investigate a possible inhibition of the bactericidal effect of vancomycin by tranexamic acid, adrenalin, lidocaine, or dexamethasone. The bactericidal effect of vancomycin was quantified using the established method of the agar diffusion test. The plates were incubated with Staphylococcus aureus or Staphylococcus epidermidis and four wells were stamped out. The wells were filled with vancomycin alone, the tested substance alone or a mixture of the two. The fourth well remained empty as a control. The plates were incubated overnight at 37 °C and the zone of inhibition in each field was measured on the next day. All tests were run three times for each pathogen and mean values and standard deviations of the measurements were calculated. Differences between the substances were tested using the t-test at a level of significance of 0.05. The bacterial growth was homogeneous on all plates. The baseline value for the zone of inhibition of vancomycin was on average 6.2 ± 0.4 mm for Staphylococcus aureus and 12 ± 0.3 mm for Staphylococcus epidermidis. In all other substances, no inhibition was detected around the well. The combination of vancomycin and each other substance did not show any different result compared to vancomycin alone. The bactericidal effect of vancomycin on staphylococci is not altered by tranexamic acid, adrenalin, dexamethasone, or lidocaine in vitro.


Transfusion ◽  
2016 ◽  
Vol 57 (3) ◽  
pp. 622-629 ◽  
Author(s):  
Joseph F. Styron ◽  
Alison K. Klika ◽  
Caleb R. Szubski ◽  
Deborah Tolich ◽  
Wael K. Barsoum ◽  
...  

2018 ◽  
Vol 33 (10) ◽  
pp. 3365-3368.e1 ◽  
Author(s):  
Xiang-Dong Wu ◽  
Ke-Jia Hu ◽  
Ya-Ying Sun ◽  
Yu Chen ◽  
Wei Huang

2017 ◽  
Vol 37 ◽  
pp. 116-122 ◽  
Author(s):  
Michael Nurok ◽  
Jennifer Cheng ◽  
Giulio R. Romeo ◽  
Stephanie M. Vecino ◽  
Kara G. Fields ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document